- Home
- VALU vs TLRY Comparison
VALU vs TLRY Comparison
Compare VALU & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- TLRY
- Stock Information
- Founded
- VALU 1931
- TLRY N/A
- Country
- VALU United States
- TLRY Canada
- Employees
- VALU N/A
- TLRY N/A
- Industry
- VALU Investment Managers
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- VALU Finance
- TLRY Health Care
- Exchange
- VALU Nasdaq
- TLRY Nasdaq
- Market Cap
- VALU 358.0M
- TLRY 426.2M
- IPO Year
- VALU N/A
- TLRY 2018
- Fundamental
- Price
- VALU $38.44
- TLRY $0.60
- Analyst Decision
- VALU
- TLRY Hold
- Analyst Count
- VALU 0
- TLRY 2
- Target Price
- VALU N/A
- TLRY $1.38
- AVG Volume (30 Days)
- VALU 2.4K
- TLRY 39.3M
- Earning Date
- VALU 07-25-2025
- TLRY 07-28-2025
- Dividend Yield
- VALU 3.31%
- TLRY N/A
- EPS Growth
- VALU 17.96
- TLRY N/A
- EPS
- VALU 2.28
- TLRY N/A
- Revenue
- VALU $35,695,000.00
- TLRY $826,656,000.00
- Revenue This Year
- VALU N/A
- TLRY $9.78
- Revenue Next Year
- VALU N/A
- TLRY $5.81
- P/E Ratio
- VALU $16.71
- TLRY N/A
- Revenue Growth
- VALU N/A
- TLRY 11.22
- 52 Week Low
- VALU $32.94
- TLRY $0.35
- 52 Week High
- VALU $57.68
- TLRY $2.15
- Technical
- Relative Strength Index (RSI)
- VALU 49.68
- TLRY 59.65
- Support Level
- VALU $37.11
- TLRY $0.39
- Resistance Level
- VALU $38.73
- TLRY $0.67
- Average True Range (ATR)
- VALU 0.71
- TLRY 0.06
- MACD
- VALU 0.00
- TLRY 0.02
- Stochastic Oscillator
- VALU 41.56
- TLRY 68.61
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.